Translational Medicine and Innovative Drug Research2023 NSFC-CAS-JSPS “转化医学与创新药物研究”学术论坛会议通知
近年来，随着健康中国战略的推动，我国新药研发与转化研究取得了长足进步，药物研发逐渐从“仿制”向“创新”过渡。但当前我国的创新药多数为“跟踪创新”（"Me too"），作为“First in class”的“源头创新”药物仍然较少。加强与国外学者的交流与合作，促进我国创新药物和转化医学的研究变得日益迫切。
NSFC-CAS-JSPS 学术研讨会发起于 2013 年，由国家自然科学基金委员会
(NSFC)、中国科学院(CAS)与日本学术振兴会（JSPS）联合举办，实施至今在搭
建中日交流平台和促进中日合作交流方面起到了非常积极的作用。
本次 NSFC-CAS-JSPS 学术论坛由天津医科大学药学院孔德新教授承办，会议主题为“转化医学与创新药物研究”。演讲嘉宾包括魏于全院士领衔的中方相关领域著名专家，以及京都大学 Hideaki Kakeya 教授等日方著名专家共二十余人。会议交流语言为英语。
会议举办时间为 2023 年 6 月 17-18 日，16 日报到，17-18 日学术报告。会场在天津赛象酒店三楼宴会厅 II。本会议不收取注册费，欢迎相关领域科研人
员、高校师生积极参加。
承办单位：天津医科大学药学院协办单位：中国抗癌协会抗癌药物专业委员会
天津医科大学总医院药剂科

2023 NSFC-CAS-JSPS ForumTranslational Medicine and Innovative Drug Research

Program of 2023 NSFC-CAS-JSPS forum
转化医学与创新药物研究论坛
Chair：Dexin Kong
Address: Saixiang Grand Ballroom II , the 3rd floor,（3F 宴会厅 II）, Tianjin Saixiang Hotel.
Time (17/06)

08:30-09:00

Title
Greetings from Chair (5 min)Greetings from NSFC (5 min)Greetings from CAS (5 min)Greetings from JSPS (10 min)Greetings from TMU (5 min)Speaker
Dexin Kong（孔德新）Wencong Li（李文聪）Haitao Chen（陈海涛）Hideyuki Yamaguchi
Xiongwen Chen（陈雄文）09:00-09:15

Group photo （Saixiang Grand Ballroom I, the 3rd floor；3F 宴会厅 I）

09:15-10:00(online)10:00-10:30(online)10:30-10:45

COVID-19 vaccines induce protective immunity against
Yuquan Wei（魏于全）(Sichuan Univ.四川大学, China)
Omicron variant
Hideaki Kakeya
Development of an innovative anticancer drug TBP1901, aninjectable prodrug of curcumin(Kyoto Univ.京都大学, Japan)
Tea break

10:45-11:15

Key molecular events leading to chronicity of inflammationand their targeting
Intracellular Molecular-Targeted Photodynamic Therapy

2023 NSFC-CAS-JSPS Forum

Huabing Sun（孙华冰）Xiongwen Chen(陈雄文)Qiang Xu（徐强）(Nanjing Univ.南京大学, China)
Hiroyuki Nakamura

11:15-11:45

Host(Tokyo Institute of Technology 东京工业大学, Japan)

Min Huang（黄敏）

Translational Medicine and Innovative Drug Research

11:45-13:30
13:30-14:00
14:00-14:30
14:30-15:00

Lunch （Café De Tresor, the 1st floor；1F 璀璨咖啡厅）Development of personalized exosome immunotherapy
vaccines for tumor
Dependence of translocation-related sarcomas on PI3K isoforms
and their potentials as therapeutic targets
Medicinal Chemistry of Cancer Stem Cell and Global Clinical
Trials

15:00-15:15

Tea break

15:15-15:45

Discovery and Biosynthesis of Anti-infective Natural Products
from Marine-Derived Microorganisms

15:45-16:15

The revolutionary strategy for preventing cancer metastases

Haifang Yin（尹海芳）(Tianjin Medical Univ.天津医科大学,China)

Shingo Dan(JFCR 日本癌症研究所, Japan)

Qiang Xu（徐强）

Yue Chen（陈悦）(Nankai Univ.南开大学, China)

Jianhua Ju（鞠建华）(Shandong Univ.山东大学, China)

Yue Chen

Lee Jia （贾力）（陈悦）

(Minjiang Univ.闽江学院, China)

Jianguo Gu
16:15-16:45

16:45-17:15

Functional analysis of N-glycan in cancers and its application

Exploiting Metabolic Vulnerabilities in Cancer Therapy(Tohoku Medical and PharmaceuticalUniv.东北医科药科大学, Japan)

Lee Jia

Min Huang（黄敏）(贾力)(Shanghai Institute of Materia Medica, CAS中科院上海药物所, China)

17:30~

Dinner （Saixiang Grand Ballroom I , the 3rd floor；3F 宴会厅 I）

2023 NSFC-CAS-JSPS ForumTranslational Medicine and Innovative Drug Research靶向治疗与创新药物研究论坛
Chair：Dexin Kong
Address: Saixiang Grand Ballroom II, the 3rd floor（3F 宴会厅 II）, Tianjin Saixiang Hotel.
Time (18/06)

TitleSpeaker

HostJian-Ting Zhang

09:00-09:30(online)Targeting FASN from Laboratory Studies to Clinical Trials

09:30-10:00(online)Loss of PRMT7 reprograms glycine metabolism to selectively
eradicate leukemia stem cells in CML

10:00-10:30(online)Strategies for Overcoming Multidrug Resistance with Nanodrugs

10:30-10:45(online)Tea break

10:45-11:15(online)

ALKBH5-mediated m6A demethylation in resistance to HER2targeted therapy in breast cancer

11:15-11:45(online)Protein homeostasis in cancer therapy: target identification and drug
discovery(Univ. of Toledo College ofMedicine and Life Sciences, USA)2023 NSFC-CAS-JSPS ForumJingxuan Pan（潘景轩）(Sun Yat-Sen Univ.中山大学, China)

Zhijie Chang（常智杰）

Zhe-Sheng (Jason) Chen
(St. John's Univ., USA)

Bolin Liu
(LSU Health Sciences Center, USA)Bo Yang（杨波）(Zhejiang Univ.浙江大学, China)

Ke Li（李珂）Translational Medicine and Innovative Drug Research

11:45-13:30
13:30-14:00(online)Lunch（Café De Tresor, the 1st floor；1F 璀璨咖啡厅）Contribution of Academic Research Organizations to Developmentof Innovative Medical Products

14:00-14:30(online)Crossroads of telomere biology and anticancer drug discovery

14:30-15:00

Onco-protein CREPT promotes gene expression via promoter
activation and transcriptional loop formation

15:00-15:30

Precision drug development for complex diseases based on geneticevidence

15:30-15:45
15:45-16:15
16:15-16:45
16:45-17:00
17:30~

Atsuhiko Kawamoto(Translational research center for
medical innovation, Japan)

Hiroyuki Seimiya

Jianguo Gu（顾建国）(JFCR 日本癌症研究所, Japan)

Zhijie Chang（常智杰）(Tshinghua Univ. 清华大学,China)

Mulin Jun Li（李俊）(Tianjin Medical Univ.

HuabingSun（孙华冰）天津医科大学, China)

Tea breakThe real role of pseudokinase
Inducible DNA Damaging Agents and Their
Potent and Selective Antitumor Activities
Closing remarks

Ke Li（李珂）(PUMC 协和药生所, China)

Huabing Sun（孙华冰）(Tianjin Medical Univ.

（龚珉）

天津医科大学, China)

Dexin Kong （孔德新）Dinner（Café De Tresor, the 1st floor；1F 璀璨咖啡厅）

2023 NSFC-CAS-JSPS ForumMin Gong